Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study) Meeting Abstract
| Authors: | González Martín, A.; Pothuri, B.; Vergote, I. B.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; Backes, F.; Baumann, K.; Redondo, A.; Moore, R. G.; Vulsteke, C.; O'Cearbhaill, R. E.; Lund, B.; Li, Y.; Gupta, D.; Monk, B. J. |
| Abstract Title: | Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz394.052 |
| Language: | English |
| ACCESSION: | WOS:000491295500125 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz394.052 |
| Notes: | Meeting Abstract: LBA1 -- Appears on page v893 of the abstract book -- Source: Wos |
